Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Gains from Sales and Divestitures (2018 - 2020)

vTv Therapeutics' Gains from Sales and Divestitures history spans 3 years, with the latest figure at $11667.0 for Q4 2020.

  • For Q4 2020, Gains from Sales and Divestitures changed 0.01% year-over-year to $11667.0; the TTM value through Dec 2020 reached $11667.0, changed 0.01%, while the annual FY2020 figure was $11667.0, 0.01% changed from the prior year.
  • Gains from Sales and Divestitures for Q4 2020 was $11667.0 at vTv Therapeutics, roughly flat from $11667.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $11667.0 in Q2 2018 and bottomed at $11666.0 in Q1 2018.
  • The 3-year median for Gains from Sales and Divestitures is $11667.0 (2018), against an average of $11666.6.
  • The largest annual shift saw Gains from Sales and Divestitures decreased 0.01% in 2019 before it increased 0.01% in 2020.
  • A 3-year view of Gains from Sales and Divestitures shows it stood at $11667.0 in 2018, then dropped by 0.01% to $11666.0 in 2019, then increased by 0.01% to $11667.0 in 2020.
  • Per Business Quant, the three most recent readings for VTVT's Gains from Sales and Divestitures are $11667.0 (Q4 2020), $11667.0 (Q3 2020), and $11667.0 (Q2 2020).